Mr. Speaker, the use of massive amounts of human antibiotics for non-therapeutic purposes in industrial food animal production is seriously jeopardizing the health of Americans. This practice is contributing to the emergence and spread of…
Mr. Speaker, the use of massive amounts of human antibiotics for non-therapeutic purposes in industrial food animal production is seriously jeopardizing the health of Americans. This practice is contributing to the emergence and spread of antibiotic- resistant bacteria, often rendering ineffective human life-savings drugs.
I am submitting for the record a letter to the White House, signed by twenty reputable organizations such as the Infectious Diseases Society of America, American Medical Association, American Academy of Pediatrics, and Pew Charitable Trusts, which supports the Food and Drug Administration's early steps to phase out the use of antibiotics for growth promotion and feed efficiency in food animals, and calls on the Administration to go further.
July 24, 2009.
Ms. Melody Barnes,
Assistant to the President for Domestic Policy, The White
House, Washington, DC.
Dear Ms. Barnes: As organizations committed to protecting
patients, public health, animal health, and food safety, the
undersigned groups are writing to express our grave concern
about the misuse of antibiotics in agriculture and our strong
support for the Administration's new ``public health approach
to antimicrobial use in animals,'' which was articulated by
the Food and Drug Administration (FDA) in its July 13th
statement before the Rules Committee of the U.S. House of
Representatives. The Obama Administration's leadership in
providing a clear path forward on this highly politically
charged issue is very much welcomed after decades of inertia.
Our combined memberships include the country's foremost
scientific and medical experts and represent more than eleven
million concerned Americans and health professionals. Our
position is based on objective health interests and concerns
that dangerous drug resistant infections are rapidly
increasing in hospitals and community settings adding to the
economic burden of the U.S. healthcare costs.
Specifically, we support the FDA's calls for phasing out
the use of antimicrobial drugs for growth promotion and feed
efficiency, and for requiring that all other uses of these
drugs be carried out under the supervision of a veterinarian
and within the boundaries of a valid veterinarian-client-
patient relationship--which we expect will end over-the-
counter sales of tons of antimicrobial drugs annually. We
also support the agency's expressed intent to clearly define
the limited instances where antimicrobials may be used
judiciously in food animals for purposes of disease
prevention and control and are eager to work with FDA to
ensure that the policy developed is the most protective of
public health. We also urge the agency to make the new
antimicrobial policy mandatory, retroactive to already-
approved drugs, and enforceable, in order to best guarantee a
significant reduction in antimicrobial use. The
Administration's statement clearly demonstrates a commitment
to sound and science-based policies that are backed up by
scores of scientific and medical publications and will
protect the health of every American.
The development of antimicrobial agents to treat life-
threatening infections has been one of the most notable
medical achievements of the past century. Physicians,
healthcare professionals, and public health and food safety
advocates are greatly concerned about the growing body of
scientific evidence demonstrating that antimicrobial drug use
in livestock and poultry contributes to the spread of drug-
resistant bacteria to people. Drug-resistant organisms are
plaguing Americans, including otherwise healthy individuals,
in healthcare settings and communities across the country. We
are pleased that these concerns finally are being recognized
and addressed by the federal government to forestall
epidemics of untreatable infections.
Fundamental to FDA's new approach--and our support for it--
are the principles that: ``protecting public health requires
the judicious use in animal agriculture of those
antimicrobials of importance in human medicine'' and that
``purposes other than for the advancement of animal and human
health should not be considered judicious use.''--Dr. Joshua
Sharfstein, FDA's Principal Deputy Commissioner, July 13,
2009.
The Administration's vision to eliminate non-judicious uses
of antimicrobial drugs, including for purposes of growth
promotion and feed efficiency and non-judicious disease
prevention which have been practiced in animal agriculture
for several decades, demonstrates a critical public policy
shift that will better protect the public against resistant
infections and preserve the power of existing antibiotics. In
addition, we urge FDA to formalize its position on veterinary
supervision of all antimicrobial uses and ending the over-
the-counter sale of antibiotics for animal agricultural uses,
which are long-overdue. The sale of antimicrobials for use in
human medicine requires a prescription; there is no reason to
permit a lower standard for agricultural purposes where
considerably more antimicrobial drugs are used annually.
The Administration's new policy direction appears intended
to reflect the concerns of a broad consensus of the
scientific, medical, public health and international health
communities. Such consensus is buttressed by the actions of
expert bodies and governments. For example:
Since 2002, the World Health Organization (WHO) has called
upon all nations to shift from use of antimicrobials in non-
human medicine.
In 2003, the Institute of Medicine (IOM) of the National
Academies of Science called on the FDA to ban the use of
antimicrobials for growth promotion in animals, if those
drugs were also used in human medicine.
In 2006, the European Union banned non-therapeutic use of
antimicrobials, because such use was found to raise food
safety concerns, and the ban was instituted to protect
against further development of antimicrobial resistance.
We recognize that phasing out of antimicrobials for non-
judicious uses in animals will require changes in the
agricultural industry. But protection of the public's health
must come first, and the phase out can be conducted in a way
that that minimizes costs to the agriculture industry.
Farmers in Europe have adapted to such a policy without undue
disruption of production or increased consumer costs; the
United States can learn from that experience while also
protecting American lives. In addition, the U.S. Department
of Agriculture has recognized that various production methods
used in the United States today are viable alternatives to
non judicious antimicrobial uses and such alternatives are
employed with little negative--or even with somewhat
positive--economic impact to producers.
We urge you to maintain the scientifically sound positions
the Administration already has taken in support of phasing
out growth promotion and feed efficiency uses, and to
finalize a policy that will strictly manage a narrow set of
prophylactic uses while mandating veterinary-patient
relationships and eliminating the over-the-counter sale of
antibiotics for use in animals.
We remain committed to working with the Administration to
implement these new approaches in ways that will best protect
the lives and health of both humans and animals.
Sincerely,
Alliance for the Prudent Use of Antibiotics.
American Academy of Pediatrics.
American Association of Critical-Care Nurses.
American Medical Association.
American Pharmacists Association.
American Public Health Association.
American Society of Health-System Pharmacists.
Association for Professionals in Infection Control and
Epidemiology.
Food Animal Concerns Trust.
Humane Society of the United States.
Infectious Diseases Society of America.
Institute for Agriculture and Trade Policy.
Keep Antibiotics Working.
Michigan Antibiotic Resistance Reduction Coalition.
National Association of County and City Health Officials.
Pew Campaign on Human Health and Industrial Farming.
Premier, a healthcare alliance serving 2,100 nonprofit
hospitals and 58,000 healthcare sites.
Society of Infectious Diseases Pharmacists.
Trust for America's Health.
Union of Concerned Scientists.